A committee co-chaired by Prof. Richard Hynes has presented a set of guidelines for using the CRISPR gene-editing tool in humans, reports Lauran Neergaard for the AP. Neergaard writes that Hynes noted, “safety is one reason for caution, as scientists will have to learn whether editing one gene has unwanted downstream effects.”
Washington Post reporter Joel Achenbach writes that a committee co-chaired by Prof. Richard Hynes has presented a series of guidelines for applying CRISPR gene editing in humans. “We say proceed with all due caution, but we don’t prohibit germline, after considerable discussion and debate,” says Hynes. “We’re talking only about fixing diseases.”
Boston Herald reporter Lindsay Kalter writes that Prof. Ed Boyden is working on a new effort to develop technologies that would allow doctors to explore tumors using virtual reality. Boyden explains that he and his colleagues hope to use virtual reality to explore “what a tumor’s weaknesses are, and what makes it thrive.”
In an article for Slate, Prof. Kevin Esvelt argues for the importance of keeping scientific research open and publically accessible, in particular when it comes to gene editing. “Scientific journals, funders, policymakers, and intellectual property holders should change the incentives to ensure that all proposed gene drive experiments are open and responsive,” writes Esvelt.
Cynthia Graber writes for The Boston Globe Magazine that MIT researchers developed a robot to collect sewage samples, in an effort to gain a better understanding of public health problems. The samples can pinpoint harmful environmental factors as well as “neighborhoods with high rates of infectious diseases or even obesity, levels of illegal drug use, and pollutants.”
In this piece for The New Yorker, Michael Specter writes about Prof. Kevin Esvelt’s idea to use gene-editing technology to eradicate Lyme disease. “This is an ecological problem,” Esvelt explains. “And we want to enact an ecological solution so that we break the transmission cycle that keeps ticks in the environment infected with these pathogens.”
Prof. James Collins has been named one of The Boston Globe’s “2016 Bostonians of the Year” for his work developing a paper-based test that can detect the Zika virus in just a few hours. Neil Swidey notes that Collins also developed a “workflow for how this new platform could be adapted to meet future crises.”
MIT researchers have found that flashing lights could potentially be used to stave off Alzheimer’s disease, writes Oscar Williams for The Huffington Post. “Light stimulation directed to the hippocampus, the part of the brain that processes memories, led to a reduction of…beta amyloid,” which is found in Alzheimer’s disease.
Financial Times reporter Clive Cookson writes that MIT researchers have found evidence that flashing lights could potentially be used as a noninvasive treatment for Alzheimer’s disease. The researchers found that “lights flashing on and off 40 times per second restored ‘gamma oscillation’ waves that were suppressed in the disease.”
MIT researchers have found that flashing light may reduce the buildup of beta amyloid protein in the brain, which is associated with Alzheimer’s disease, writes Michelle Roberts for the BBC News. The researchers hope that “clearing beta amyloid and stopping more plaques from forming could halt Alzheimer's and its symptoms.”
Writing for The Atlantic, Ed Yong spotlights a study by MIT researchers that identifies a potential new treatment for Alzheimer’s – using pulses of light to stimulate brain waves. Yong writes that the study “heralds a completely new approach to dealing with Alzheimer’s—changing neural activity, rather than delivering drugs or chemicals.”
MIT researchers have found that exposure to flickering lights at a precise frequency may help fight off Alzheimer’s disease, reports Melissa Healy for The Los Angeles Times. The technique recruits “neurons and other cell types in the brain to sort of enable the brain’s inner ability to repair itself,” explains Prof. Li-Huei Tsai, director of the Picower Institute.
Guardian reporter Hannah Devlin writes about a new study by MIT researchers that shows that strobe lighting can reduce levels of toxic proteins found in Alzheimer’s disease. The researchers found that “exposure to flickering light stimulated brain waves, called gamma oscillations, that are known to be disturbed in Alzheimer’s patients.”
In an article for Popular Science, Kate Baggaley speaks with Prof. Timothy Lu and postdoc César de la Fuente about strategies they are developing to tackle antibiotic resistance. Lu explains that researchers are attempting to develop an arsenal of treatments to “be able to come at the problem from a variety of different ways.”
Straits Times reporter Nadia Chevroulet writes that researchers from MIT and the Singapore-MIT Alliance for Research and Technology (SMART) have uncovered how certain bacteria evade the body’s defenses. The findings could provide “new ways to counter tuberculosis, and possibly a new generation of drugs to battle antibiotic resistance.”